Our data are consistent with the results of a study by Sellmeer & Singer [17], which showed that the serum NT-proBNP concentrations on the third day of life could reliably predict the development of BPD/death in infants < 32 weeks of gestation (AUC = 0.76; 95% CI: 0.68–0.84). Here, NPPB is linked to bronchopulmonary dysplasia.